These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18528893)

  • 1. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology.
    Gokden N; Kemp SA; Gokden M
    Diagn Cytopathol; 2008 Jul; 36(7):473-7. PubMed ID: 18528893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry for the detection of renal cell carcinoma in effusion cytology.
    Chute DJ; Kong CS; Stelow EB
    Diagn Cytopathol; 2011 Feb; 39(2):118-23. PubMed ID: 21254459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
    Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pax-2 expression in adult renal tumors.
    Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
    Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
    Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
    Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX2 expression in Wilms tumors and other childhood neoplasms.
    Davis JL; Matsumura L; Weeks DA; Troxell ML
    Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA; Bastacky SI; Myers EN; Hunt JL
    Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
    Fetsch PA; Powers CN; Zakowski MF; Abati A
    Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
    J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
    Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
    Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
    Browning L; Bailey D; Parker A
    J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
    He H; Zhou GX; Zhou M; Chen L
    Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.
    Memeo L; Jhang J; Assaad AM; McKiernan JM; Murty VV; Hibshoosh H; Tong GX; Mansukhani MM
    Am J Clin Pathol; 2007 Feb; 127(2):225-9. PubMed ID: 17210525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration.
    Wasco MJ; Pu RT
    Diagn Cytopathol; 2008 Aug; 36(8):568-73. PubMed ID: 18618717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.
    Ozcan A; Zhai J; Hamilton C; Shen SS; Ro JY; Krishnan B; Truong LD
    Am J Clin Pathol; 2009 Mar; 131(3):393-404. PubMed ID: 19228645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
    Chivukula M; Dabbs DJ; O'Connor S; Bhargava R
    Int J Gynecol Pathol; 2009 Nov; 28(6):570-8. PubMed ID: 19851209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.
    Ozcan A; Zhai Q; Javed R; Shen SS; Coffey D; Krishnan B; Truong LD
    Arch Pathol Lab Med; 2010 Aug; 134(8):1121-9. PubMed ID: 20670131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.